Literature DB >> 29157611

Epidemiology of Castleman Disease.

David Simpson1.   

Abstract

Castleman disease is a rare entity, including unicentric Castleman disease (UCD), human herpesvirus-8 plus Castleman disease (HHV-8+MCD), and idiopathic multicentric Castleman disease (iMCD). UCD is the most common at 16 per million person years and occurs at every age. HHV-8+MCD incidence varies widely, mostly affecting human immunodeficiency virus-positive men. iMCD is likely a more heterogeneous disease with an estimated incidence of 5 per million person years. Improved definitions should improve understanding of the epidemiology of Castleman disease and its subtypes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HHV-8; Multicentric Castleman; TAFRO; Unicentric Castleman

Mesh:

Year:  2018        PMID: 29157611     DOI: 10.1016/j.hoc.2017.09.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  19 in total

1.  A mesorectal incidentaloma: Rare localization of Castleman disease (Case report).

Authors:  Daniel Ion; Alexandra Bolocan; Alexandru George Filipescu; Octavian Andronic; Ana-Maria Oproiu; Adelina Popa; Dan Nicoale Păduraru
Journal:  Exp Ther Med       Date:  2022-02-08       Impact factor: 2.447

Review 2.  Castleman disease.

Authors:  Antonino Carbone; Margaret Borok; Blossom Damania; Annunziata Gloghini; Mark N Polizzotto; Raj K Jayanthan; David C Fajgenbaum; Mark Bower
Journal:  Nat Rev Dis Primers       Date:  2021-11-25       Impact factor: 65.038

3.  Unicentric or Multicentric Castleman disease? A case report of a pelvic intraperitoneal mass in a middle aged woman.

Authors:  Antonella Smedile; Francesca Capuano; Sara Fraticelli; Marco Lucioni; Alfredo La Fianza
Journal:  J Radiol Case Rep       Date:  2019-03-31

4.  A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.

Authors:  Li Yu; Menghan Shi; Qingqing Cai; Paolo Strati; Fredrick Hagemeister; Qiongli Zhai; Ling Li; Xiaosheng Fang; Jianyong Li; Ruifang Sun; Shanxiang Zhang; Hanjin Yang; Zhaoming Wang; Wenbin Qian; Noriko Iwaki; Yasuharu Sato; Lu Zhang; Jian Li; Eric Oksenhendler; Zijun Y Xu-Monette; Ken H Young
Journal:  Oncologist       Date:  2020-09-18

Review 5.  Clinicopathological comparison and therapeutic approach to Castleman disease-a case-based review.

Authors:  Małgorzata Wojtyś; Agnieszka Piekarska; Michał Kunc; Konrad Ptaszyński; Wojciech Biernat; Jan Maciej Zaucha; Piotr Waloszczyk; Piotr Lisowski; Bartosz Kubisa; Tomasz Grodzki
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

6.  Targeting the mTOR pathway in idiopathic multicentric Castleman disease.

Authors:  Robert M Stern; Nancy Berliner
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

7.  A Case of Castleman Disease: A Diagnostic Dilemma.

Authors:  Ghulam Rabbani Anwar; Muhammad Tariq Mehr; Danial Tahir; Sidra Humayun; Ghulam Farooq
Journal:  Cureus       Date:  2021-04-08

8.  Inflammatory pseudotumor of Castleman disease and IgG4-related disease masquerading as kidney malignancy.

Authors:  Bolong Liu; Yong Huang; Luying Tang; Jiexia Guan; Xiangfu Zhou; Hailun Zhan
Journal:  Diagn Pathol       Date:  2021-08-10       Impact factor: 2.644

9.  HHV-8-Associated Multicentric Castleman Disease, a Diagnostic Challenge in a Patient With Acquired Immunodeficiency Syndrome and Fever.

Authors:  Robert Dunn; Roopam Jariwal; Frederick Venter; Shikha Mishra; Janpreet Bhandohal; Everado Cobos; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

10.  International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.

Authors:  Frits van Rhee; Peter Voorhees; Angela Dispenzieri; Alexander Fosså; Gordan Srkalovic; Makoto Ide; Nikhil Munshi; Stephen Schey; Matthew Streetly; Sheila K Pierson; Helen L Partridge; Sudipto Mukherjee; Dustin Shilling; Katie Stone; Amy Greenway; Jason Ruth; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Raj Jayanthan; Elaine S Jaffe; Heather Leitch; Naveen Pemmaraju; Amy Chadburn; Megan S Lim; Kojo S Elenitoba-Johnson; Vera Krymskaya; Aaron Goodman; Christian Hoffmann; Pier Luigi Zinzani; Simone Ferrero; Louis Terriou; Yasuharu Sato; David Simpson; Raymond Wong; Jean-Francois Rossi; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Eric Oksenhendler; David C Fajgenbaum
Journal:  Blood       Date:  2018-09-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.